These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12418935)

  • 61. A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia.
    Zhao Z
    Manag Care Interface; 2002 Feb; 15(2):75-81. PubMed ID: 11875967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L; Lavalaye J; Linszen D; Dingemans PM; Booij J
    Am J Psychiatry; 2000 Jun; 157(6):1019-20. PubMed ID: 10831489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
    Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
    Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Olanzapine: a new atypical antipsychotic.
    Littrell K; Peabody CD; Littrell SH
    J Psychosoc Nurs Ment Health Serv; 1996 Aug; 34(8):41-6. PubMed ID: 8856604
    [No Abstract]   [Full Text] [Related]  

  • 68. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
    Taylor DM; Wright T; Libretto SE;
    J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
    Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S
    J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A case of leukopenia in treatment with risperidone in an adolescent].
    Etain B; Roubaud L; Le Heuzey MF; Mouren Simeoni MC
    Encephale; 2000; 26(5):81-4. PubMed ID: 11192809
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of atypical antipsychotics in a Veterans Affairs hospital.
    Schwartz TL; Saba M; Hardoby W; Virk S; Masand PS
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1207-10. PubMed ID: 12452548
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Neuroleptics and cognition].
    Brunnauer A; Geiger E; Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S106-9. PubMed ID: 14509053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
    Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A
    Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Eruptive xanthomas associated with olanzapine use.
    Chang HY; Ridky TW; Kimball AB; Hughes E; Oro AE
    Arch Dermatol; 2003 Aug; 139(8):1045-8. PubMed ID: 12925394
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Olanzapine-induced reversible priaprism: a case report.
    Deirmenjian JM; Erhart SM; Wirshing DA; Spellberg BJ; Wirshing WC
    J Clin Psychopharmacol; 1998 Aug; 18(4):351-3. PubMed ID: 9690708
    [No Abstract]   [Full Text] [Related]  

  • 78. Effectiveness and cost of risperidone and olanzapine for schizophrenia: a systematic review.
    Hargreaves WA; Gibson PJ
    CNS Drugs; 2005; 19(5):393-410. PubMed ID: 15907151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia.
    Cooper D; Moisan J; Gaudet M; Abdous B; Grégoire JP
    Can J Psychiatry; 2005 Dec; 50(14):901-8. PubMed ID: 16494259
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of olanzapine and risperidone in schizophrenia: a randomized double-blind crossover design.
    Canive JM; Miller GA; Irwin JG; Moses SN; Thoma RJ; Edgar JC; Sherwood A; Torres F; Lanoue M; Lewis S; Hanlon FM; Weisend MP; Mead V; Tuason VB
    Psychopharmacol Bull; 2006; 39(1):105-16. PubMed ID: 17065975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.